Gene · 6480
Papers1,665
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,665
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Antigenic Dark Matter: Unexplored Post-Translational Modifications of Tumor-Associated and Tumor-Specific Antigens in Pancreatic Cancer. | Cancers (Basel) | 2025 | 41228299 | PubTator, text mining | PubMed |
| Sialylation Inhibition Impairs Migration and Promotes Adhesion of GBM Cells. | Int J Mol Sci | 2025 | 41226744 | PubTator, text mining | PubMed |
| The relationship of ST6GAL1 with clinicopathological and prognostic factors in breast carcinomas. | Saudi Med J | 2025 | 41224336 | PubTator, text mining | PubMed |
| ST6GAL1-mediated sialylation inhibits the antitumor immune response in colorectal cancer. | Cell Oncol (Dordr) | 2025 | 41217711 | PubTator, text mining | PubMed |
| Extracellular vesicles: cargo loading, degradation and secretory pathways, and their intersection with autophagy. | Extracell Vesicles Circ Nucl Acids | 2025 | 41132500 | PubTator, text mining | PubMed |
| HPV as a Molecular Hacker: Computational Exploration of HPV-Driven Changes in Host Regulatory Networks. | Viruses | 2025 | 41012596 | PubTator, text mining | PubMed |
| Age-related remodeling of the sialoglycans dampens murine CD8+ T cell function. | Sci Adv | 2025 | 41004592 | PubTator, text mining | PubMed |
| Advancements in the diagnosis and management of capecitabine-induced hand-foot syndrome. | J Cancer Res Clin Oncol | 2025 | 40976784 | PubTator, text mining | PubMed |
| Regulated expression of galectins 1 and 3 IS associated with dysregulated T cell responses in pulmonary and pleural tuberculosis. | Med Microbiol Immunol | 2025 | 40952516 | PubTator, text mining | PubMed |
| B-Cell ST6Gal1/Neuraminidase 1 Ratios Inversely Predict the Combined Remission and Low-Disease-Activity Subgroup with DAS28-MCP-1 and SDAI Scores for Rheumatoid Arthritis. | Int J Mol Sci | 2025 | 40943151 | PubTator, text mining | PubMed |
| A novel sialylation pathway mediated by extracellular vesicles in aggressive prostate cancer. | PLoS One | 2025 | 40938891 | PubTator, text mining | PubMed |
| The role of protein glycosylation in colorectal cancer: From molecular pathways to clinical applications. | Biochim Biophys Acta Rev Cancer | 2025 | 40930262 | PubTator, text mining | PubMed |
| Novel lithocholic acid-diindolylmethane hybrids as potent sialyltransferase inhibitors targeting triple-negative breast cancer: a molecular hybridization approach. | RSC Med Chem | 2025 | 40896419 | PubTator, text mining | PubMed |
| Decoding rheumatoid arthritis: Biomarker identification and immune profiling via bioinformatics and Mendelian randomization. | Medicine (Baltimore) | 2025 | 40859487 | PubTator, text mining | PubMed |
| A Cancer-Specific Anti-Podocalyxin Monoclonal Antibody (humPcMab-60) Demonstrated Antitumor Efficacy in Pancreatic and Colorectal Cancer Xenograft Models. | Antibodies (Basel) | 2025 | 40843679 | PubTator, text mining | PubMed |
| GALNT7 Stratifies dMMR/MSI Colorectal Cancer into Distinct Molecular Subsets Associated with Prognosis and PD-L1 Expression. | Cancer Res Commun | 2025 | 40824763 | PubTator, text mining | PubMed |
| Structural convergence and water-mediated substrate mimicry enable broad neuraminidase inhibition by human antibodies. | Nat Commun | 2025 | 40750617 | PubTator, text mining | PubMed |
| New insights into genetic comorbidity mechanisms: type 2 diabetes and primary open-angle glaucoma. | BMJ Open Ophthalmol | 2025 | 40669929 | PubTator, text mining | PubMed |
| Machine learning-based integration identifies plasma cells-related gene signature ST6GAL1 in idiopathic pulmonary fibrosis. | BMC Pulm Med | 2025 | 40604645 | PubTator, text mining | PubMed |
| ST6GAL1 promotes IBD B cell recruitment to the inflamed colon in a CD22-dependent mechanism. | J Crohns Colitis | 2025 | 40491026 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6480/papers?page=4